Citation Impact
Citing Papers
Topographical and Temporal Diversity of the Human Skin Microbiome
2009 StandoutScience
IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2–dependent mechanisms with implications for psoriasis pathogenesis
2006
Autoimmune Th17 Cells Induced Synovial Stromal and Innate Lymphoid Cell Secretion of the Cytokine GM-CSF to Initiate and Augment Autoimmune Arthritis
2018 StandoutNobel
Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people: systematic review and economic evaluation
2017
Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial
2005
Infliximab induction therapy for patients with severe plaque-type psoriasis: A randomized, double-blind, placebo-controlled trial
2004
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Inflammation and cancer
2002 StandoutNature
Updated consensus statement on biological agents, specifically tumour necrosis factor α (TNFα) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2004
2004
Genome-wide association scan yields new insights into the immunopathogenesis of psoriasis
2009
Psoriasis
2009 Standout
Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose
2008 Standout
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial
2005
Pathogenic role for skin macrophages in a mouse model of keratinocyte-induced psoriasis-like skin inflammation
2006
Pathogenesis and clinical features of psoriasis
2007 Standout
The Emerging Role of IL-17 in the Pathogenesis of Psoriasis: Preclinical and Clinical Findings
2012
TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity
2007 StandoutNobel
Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)
2008 Standout
Differentiating the efficacy of the tumor necrosis factor inhibitors
2005
Pathogenesis and therapy of psoriasis
2007 StandoutNature
Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: Results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT)
2005
Differences in the incidence of flares or new onset of inflammatory bowel diseases in patients with ankylosing spondylitis exposed to therapy with anti–tumor necrosis factor α agents
2007
Updated consensus statement on biological agents, specifically tumour necrosis factor α (TNFα) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2005
2005
Activation of dendritic antigen-presenting cells expressing common heat shock protein receptor CD91 during induction of psoriasis.
2005
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
TNF receptor 2 pathway: drug target for autoimmune diseases
2010
Programmed cell death of keratinocytes in infliximab-treated plaque-type psoriasis
2006
Psoriasis
2021 Standout
Etanercept therapy for patients with psoriatic arthritis and concurrent hepatitis C virus infection: Report of 3 cases
2004
Tumor Necrosis Factor-α Blockade: A Novel Therapy for Rheumatic Disease
2002
Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway
1999 StandoutNobel
Gout
2009 Standout
Advancements in the Treatment of Psoriasis: Role of Biologic Agents
2004
Osteoarthritis
2015 Standout
The pathogenic role of tissue-resident immune cells in psoriasis
2007
Macrophage Diversity Enhances Tumor Progression and Metastasis
2010 Standout
Psoriasis and Pustular Dermatitis Triggered by TNF-α Inhibitors in Patients With Rheumatologic Conditions
2007
The experience of pain and emergent osteoarthritis of the knee
2001
Psoriasis
2015 Standout
Interleukin-17 and Type 17 Helper T Cells
2009 Standout
Psoriasis: emerging therapeutic strategies
2005
Graves' Ophthalmopathy
2010 Standout
Conditions required for myelopoiesis in murine spleen
1993
Cellular and Molecular Mechanisms in the Regulation and Function of Osteoclasts
1991
Hematopoietic stem cell compartment: Acute and late effects of radiation therapy and chemotherapy
1995
The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games
2005
A β-arrestin 2 Signaling Complex Mediates Lithium Action on Behavior
2008 StandoutNobel
Resolution of psoriasis upon blockade of IL-15 biological activity in a xenograft mouse model
2003
Pharmacodynamic and pharmacokinetic response to anti-tumor necrosis factor-α monoclonal antibody (infliximab) treatment of moderate to severe psoriasis vulgaris
2003
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
2010 Standout
Gout
2016 Standout
Immunity, Inflammation, and Cancer
2010 Standout
Incidence and importance of antibody responses to infliximab after maintenance or episodic treatment in Crohn’s disease
2004
The long-term efficacy and safety of new biological therapies for psoriasis
2006
Taking dendritic cells into medicine
2007 StandoutNatureNobel
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Cells and Molecules that Regulate B Lymphopoiesis in Bone Marrow
1989
Innate and adaptive immunity and the pathophysiology of psoriasis
2006
The immunologic basis for the treatment of psoriasis with new biologic agents
2002
Heterogeneity of autoimmune diseases: pathophysiologic insights from genetics and implications for new therapies
2015
Psoriasis
2003
IL-22 is required for Th17 cell–mediated pathology in a mouse model of psoriasis-like skin inflammation
2008
British Society for Rheumatology and British Health Professionals in Rheumatology Guideline for the Management of Gout
2007
Resolution of endothelial activation and down-regulation of Tie2 receptor in psoriatic skin after infliximab therapy
2006
Febuxostat Compared with Allopurinol in Patients with Hyperuricemia and Gout
2005 Standout
Psoriasis vulgaris: cutaneous lymphoid tissue supports T-cell activation and ‘Type 1’ inflammatory gene expression
2004
Treatment of refractory psoriatic arthritis with infliximab: a 12 month observational study of 16 patients
2004
Psoriasis
2005
Tumour necrosis factor and cancer
2009
Etanercept as Monotherapy in Patients with Psoriasis
2003
The IL-12 Family Member p40 Chain as a Master Switch and Novel Therapeutic Target in Psoriasis
2004
The British Association of Dermatologists’ Biologic Interventions Register (BADBIR): design, methodology and objectives
2012
Development of anti-TNF therapy for rheumatoid arthritis
2002
The evaluation of psoriasis therapy with biologics leads to a revision of the current view of the pathogenesis of this disorder
2006
Efficacy and tolerability of biologic and nonbiologic systemic treatments for moderate-to-severe psoriasis: meta-analysis of randomized controlled trials
2008
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
2010 Standout
A Phase I Study Evaluating the Safety, Pharmacokinetics, and Clinical Response of a Human IL-12 p40 Antibody in Subjects with Plaque Psoriasis
2004
Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial
2005
Dual neutralization of both interleukin 17A and interleukin 17F with bimekizumab in patients with psoriasis: Results from BE ABLE 1, a 12-week randomized, double-blinded, placebo-controlled phase 2b trial
2018
Anti-TNF Antibody Therapy in Rheumatoid Arthritis and the Risk of Serious Infections and Malignancies
2006 Standout
α1β1 integrin is crucial for accumulation of epidermal T cells and the development of psoriasis
2007
Management of Acute and Chronic Gouty Arthritis
2004
Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials
2014 Standout
Tumor Necrosis Factor Inhibits Spread of Hepatitis C Virus Among Liver Cells, Independent From Interferons
2017 StandoutNobel
Binding and Functional Comparisons of Two Types of Tumor Necrosis Factor Antagonists
2002
Assessment of patients with psoriatic arthritis: A review of currently available measures
2004
Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis
2006 StandoutNature
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
2005 Standout
The bcl-2 gene product inhibits clonal deletion of self-reactive B lymphocytes in the periphery but not in the bone marrow.
1993 StandoutNobel
Tissue Engineering
1993 StandoutScience
Comparison of Biologics and Oral Treatments for Plaque Psoriasis
2020
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
2005 Standout
Resolution of psoriasis upon blockade of IL-15 biological activity in a xenograft mouse model
2003
Monoclonal antibodies, immunogenicity, and associated infusion reactions.
2005
Plasmacytoid predendritic cells initiate psoriasis through interferon-α production
2005
Dendritic-cell maturation alters intracellular signaling networks, enabling differential effects of IFN-α/β on antigen cross-presentation
2006 StandoutNobel
IL-17 and Th17 Cells
2009 Standout
An Anti-IL-12p40 Antibody Down-Regulates Type 1 Cytokines, Chemokines, and IL-12/IL-23 in Psoriasis
2006
TNF Inhibition Rapidly Down-Regulates Multiple Proinflammatory Pathways in Psoriasis Plaques
2005
Recombinant murine granulocyte macrophage colony-stimulating factor has megakaryocyte colony-stimulating activity and augments megakaryocyte colony stimulation by interleukin 3.
1987
An overview of infliximab, etanercept, efalizumab, and alefacept as biologic therapy for psoriasis
2003
Thrombocytosis in patients with tumors producing colony-stimulating factor
1992 StandoutNobel
TLR2 Signaling in Chondrocytes Drives Calcium Pyrophosphate Dihydrate and Monosodium Urate Crystal-Induced Nitric Oxide Generation
2005
Increase in TNF-α and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a)
2005 StandoutNobel
Different stromal cell lines support lineage-selective differentiation of the multipotential bone marrow stem cell clone LyD9.
1991 StandoutNobel
Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
1998 Standout
Gene correction in hematopoietic progenitor cells by homologous recombination
2000 StandoutNobel
Spontaneous Development of Psoriasis in a New Animal Model Shows an Essential Role for Resident T Cells and Tumor Necrosis Factor-α
2004
Molecular Targets of Lithium Action
2001
Premature expression of the macrophage colony-stimulating factor receptor on a multipotential stem cell line does not alter differentiation lineages controlled by stromal cells used for coculture.
1991 StandoutNobel
The effect of interleukin 3 and GM-CSA-2 on megakaryocyte and myeloid clonal colony formation
1985
TNF‐mediated inflammatory disease
2007 Standout
Effects of synergistic cytokine combinations, low oxygen, and irradiated stroma on the expansion of human cord blood progenitors
1992
Etanercept therapy in patients with autoimmunity and hepatitis C
2003
Osteoarthritis: an update with relevance for clinical practice
2011 Standout
CAR T cell immunotherapy for human cancer
2018 StandoutScience
Leukocytes synthesize angiotensinogen.
1993
Pathophysiology, Clinical Presentation, and Treatment of Psoriasis
2020 Standout
Induction and exacerbation of psoriasis with TNF-blockade therapy: A review and analysis of 127 cases
2008
PanR1, a Dominant Negative Missense Allele of the Gene Encoding TNF-α (Tnf), Does Not Impair Lymphoid Development
2006 StandoutNobel
Thrombocytosis in patients with tumors producing colony-stimulating factor
1992 StandoutNobel
Works of Baker Dg being referenced
Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial
2001
Lithium stimulation of murine hematopoiesis in liquid culture: an effect mediated by marrow stromal cells
1984
Effect of a nonsteroidal antiinflammatory drug on synovial fluid in osteoarthritis.
1996
Hematopoietic regulatory factors produced in long-term murine bone marrow cultures and the effect of in vitro irradiation
1984
Comparison of the acute inflammation induced by calcium pyrophosphate dihydrate, apatite and mixed crystals in the rat air pouch model of a synovial space.
1992
Hematopoietic regulatory factors produced in long-term murine bone marrow cultures and the effect of in vitro irradiation
1984
Acute gouty arthritis is seasonal.
1998